Diplomat Pharmacy Raises $173M In IPO, Below Expectations

Law360, New York (October 10, 2014, 3:25 PM ET) -- Specialty drugmaker Diplomat Pharmacy on Thursday said it has raised $173 in its initial public offering on the New York Stock Exchange, with shares priced at $13 apiece, below the target range of $14 to $16 per share reported by media.



Of the total shares listed, 10 million belonged to the pharmacy while selling shareholders put up 3,333,333 more. Underwriters have another month to buy up to a million more shares. Diplomat, which is the largest independent specialty pharmacy in the U.S., makes drugs for patients...

To view the full article, register now.